Changing Metabolic Patterns along the Colorectal Adenoma-Carcinoma Sequence

Julia Tevini (Erstautor/-in), Sebastian Eder (Erstautor/-in), Ursula Huber-Schönauer (Co-Autor/-in), David Niederseer, Georg Strebinger, Johanna M Gostner, Elmar Aigner (Co-Autor/-in), Christian Datz, Thomas Felder* (Letztautor/-in)

*Korrespondierende/r Autor/-in für diese Arbeit

Publikation: Beitrag in FachzeitschriftOriginalarbeitBegutachtung

16 Quellenangaben (Web of Science)

Abstract

Colorectal cancer (CRC) is a major public health burden and one of the leading causes of cancer-related deaths worldwide. Screening programs facilitate early diagnosis and can help to reduce poor outcomes. Serum metabolomics can extract vital molecular information that may increase the sensitivity and specificity of colonoscopy in combination with histopathological examination. The present study identifies serum metabolite patterns of treatment-naïve patients, diagnosed with either advanced adenoma (AA) or CRC in colonoscopy screenings, in the framework of the SAKKOPI (Salzburg Colon Cancer Prevention Initiative) program. We used a targeted flow injection analysis and liquid chromatography-tandem mass spectrometry metabolomics approach (FIA- and LC-MS/MS) to characterise the serum metabolomes of an initial screening cohort and two validation cohorts (in total 66 CRC, 76 AA and 93 controls). The lipidome was significantly perturbed, with a proportion of lipid species being downregulated in CRC patients, as compared to AA and controls. The predominant alterations observed were in the levels of lyso-lipids, glycerophosphocholines and acylcarnitines, but additionally, variations in the quantity of hydroxylated sphingolipids could be detected. Changed amino acid metabolism was restricted mainly to metabolites of the arginine/dimethylarginine/NO synthase pathway. The identified metabolic divergences observed in CRC set the foundation for mechanistic studies to characterise biochemical pathways that become deregulated during progression through the adenoma to carcinoma sequence and highlight the key importance of lipid metabolites. Biomarkers related to these pathways could improve the sensitivity and specificity of diagnosis, as well as the monitoring of therapies.

OriginalspracheEnglisch
FachzeitschriftJournal of Clinical Medicine
Jahrgang11
Ausgabenummer3
DOIs
PublikationsstatusVeröffentlicht - 29 Jan. 2022

Fingerprint

Untersuchen Sie die Forschungsthemen von „Changing Metabolic Patterns along the Colorectal Adenoma-Carcinoma Sequence“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren